There is more to this than meets the eye. On a quick look, you would think that it’s all about mylotus. But a careful read and checking out videos will illustrate there is more coming. The testing device itself can be adapted to test for other conditions. Cancer for example. Anything really that can be identified with a sample. The company will likely announce a new product at any moment. So this is a great time to be in before the crowd. It will require some patience obviously. But honestly, this share price could go through the roof with a few rns’s. I like this new ceo; I think there are great moments in store for holders.
It won’t be the same. Because it looks like a buyers strike already to me. I doubt he will be able to entice any more buyers in so a delisting is probably inevitable after a failed attempt at raising more cash.